Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00415636
Status:
COMPLETED
Last Update Posted:
2018-10-19
First Post:
2006-12-21
Brief Title:
Safety and Tolerability of IC83LY2603618 Administered After Pemetrexed 500 mgm2 Every 21 Days in Patients With Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2010-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-21
First Submit QC Date:
December 21 2006
Study First Post Date:
2006-12-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-26
Last Update Post Date:
2018-10-19
Last Update Post Date Type:
ACTUAL